
View larger version (57K):
[in a new window]
|
Fig. 8. Posterior Vas localization requires vls. Wild type has two copies
of vas-eGFP. vlsnull vls+,
vlsPG65 and vlsnull have one copy of
vas-eGFP. Fixed ovaries are shown here. Live ovaries show a similar
pattern although nuage signal is generally stronger than in fixed ovaries.
(A-D) Stage 1-5 egg chambers, (A'-D') stage 10 egg chambers.
(A,A') Wild-type localization of Vas-eGFP to nuage and to the posterior
of the oocyte is observed in Sp/SM1 background. Nuage localization in
vls mutants appears normal initially (C,D) and slightly reduced in
stage 10 egg chambers (C',D'); however, we did not observe this
reduction in live ovaries (data not shown). Posterior localization of Vas-eGFP
in the oocyte is undetectable in vlsnull mutants
(D') and dramatically reduced in vlsPG65 hemizygotes
(C'). This defect is rescued by the introduction of the
vls+ transgene (B'). The levels of posterior
Vas-eGFP appear reduced in vlsnull vls+
oocytes, most probably because of the lower copy number of vas-eGFP.
(E-H') Vas-eGFP is not detected at the posterior of young embryos from
vls mutant mothers. (E-H) 0- to 1-hour-old embryos,
(E'-H') 2- to 3-hour-old embryos. Vas-eGFP accumulates at the
posterior of embryos (E,F) and then inside newly formed pole cells
(E',F') in wild-type and vlsnull
vls+ background, but not in embryos from
vlsPG65 hemizygous (G,G') and
vlsnull mutant (H,H') mothers.
|